
Shortwin DR Oral Suspension
Marketer
Orsis Pharmaceuticals
Salt Composition
Dextromethorphan Hydrobromide (10mg/5ml) + Guaifenesin (100mg/5ml) + Phenylephrine (5mg/5ml) + Chlorpheniramine Maleate (4mg/5ml)
Overview Shortwin DR Oral Suspension
Delsym Cough Relief Oral Suspension is indicated for the management of unproductive coughs. Its mechanism of action involves central cough suppression within the brain, alongside mucus thinning to facilitate expectoration. This medication also provides symptomatic relief from allergic manifestations including nasal congestion, ocular irritation, sneezing, and pharyngeal discomfort. Delsym Cough Relief Oral Suspension is administered orally, with or without food, as directed by a physician. Dosage is individualized based on patient response and clinical presentation. Consistent adherence to the prescribed regimen is crucial; premature cessation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all concurrent medications is essential, given potential interactions. Commonly reported adverse events include gastrointestinal upset (nausea, abdominal pain, diarrhea, vomiting, anorexia), headache, sleep disturbances, dermatological reactions (rash, pruritus), and these are typically transient. Prompt medical consultation is advised for any concerning side effects. Sedation is a potential effect; therefore, avoid activities demanding alertness until the medication's impact is assessed. Alcohol consumption should be avoided due to potential additive sedative effects. Self-medication and unauthorized prescription sharing are strongly discouraged. Adequate hydration is recommended during treatment. Prior to initiating therapy, inform your physician of any pre-existing hepatic, renal, or pulmonary conditions, and also of pregnancy or pregnancy planning.
Uses of Shortwin DR Oral Suspension
Persistent, unproductive cough
Major Benefits of Shortwin DR Oral Suspension:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Always consult the product label for complete instructions prior to use. Employ a measuring cup for accurate oral administration. Ensure thorough shaking before each dose. Shortwin DR Oral Suspension can be ingested with or without food; however, consistent timing is recommended for optimal efficacy.
Common Side effects of Shortwin DR Oral Suspension:
- Nausea
- Stomach pain
- Diarrhea
- Upset stomach
- Vomiting
- Loss of appetite
- Dizziness
- Headache
- Insomnia (difficulty in sleeping)
- Rash
- Hives
- Itching
- Sleepiness
How to use Shortwin DR Oral Suspension:
Administer this medication precisely as your physician prescribes, adhering to both the dosage and treatment length. Always consult the product label for instructions prior to use. Employ a measuring cup for accurate oral administration. Ensure thorough shaking before each dose. Shortwin DR Oral Suspension can be consumed with or without food; however, consistent timing is recommended for optimal results.
How Shortwin DR Oral Suspension works:
Four medications are combined in Shortwin DR Oral Suspension.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcohol and Shortwin DR Oral Suspension. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Shortwin DR Oral Suspension during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and Shortwin DR Oral Suspension are likely compatible. Available human data indicate minimal infant risk. However, elevated dosages or extended Shortwin DR Oral Suspension use might induce drowsiness or other neonatal effects.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with the use of Shortwin DR Oral Suspension.
KidneySAFE IF PRESCRIBED
Shortwin DR Oral Suspension appears safe for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary for such patients. However, physician consultation is advised. In patients experiencing end-stage renal disease, Shortwin DR Oral Suspension might induce pronounced somnolence.
LiverUNSAFE
The oral suspension, Shortwin DR, poses a likely risk for individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.
What if you forget to take Shortwin DR Oral Suspension :
Should you forget a dose of Shortwin DR Oral Suspension, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Shortwin DR Oral Suspension
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
